Tag: CLF UWS USA NAM CHN ASA

Pearl Studio and CMC Pictures Set Global Summer Release for Animated Comedy Feature All Wishes Come True!

From Pearl Studio, the Studio Behind Kung Fu Panda 3, the Mythological Comedy Marks the Next Major Chinese Animated Release as Chinese Animation Continues...

World’s First CLDN18.2 ADC for Regulatory Review: Innovent Biologics Announces IBI343 (arcotatug tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory...

SAN FRANCISCO and SUZHOU, China, June 4, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and...

Viewing China from Afar: Ganbei in Napa

NAPA, Calif., Aug. 11, 2025 /PRNewswire/ -- Historians have spent generations uncovering the vital contributions of Chinese pioneers who shaped California's celebrated Napa Valley...

Elegoo Launches Nexprint Million-Dollar Creator Fund to Reward Original Content

This is the first seven-digit fund to help creators earn from original 3D model designs. SHENZHEN, China, Aug. 8, 2025 /PRNewswire/ -- Elegoo, a rapidly...

Nature Medicine Published Phase 1 Results of Innovent Biologics’ Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

SAN FRANCISCO and SUZHOU, China, July 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality...

Synopsys Issues Statement in Connection to the Lifting of Recent U.S. Export Restrictions Related to China

SUNNYVALE, Calif., July 2, 2025 /PRNewswire/ -- Today, Synopsys, Inc. (Nasdaq: SNPS) issued the below statement in connection with the lifting of recent U.S. export...

Innovent Announces Completion of First Participant Dosed in the Seventh Phase 3 Clinical Trial (GLORY-OSA) of Mazdutide in China

SAN FRANCISCO and SUZHOU, China, June 15, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsCLF UWS USA NAM CHN ASA

CADFEM APAC and SilTerra Malaysia Partner to Advance Semiconductor Innovation Through Simulation-Driven Engineering

Westwell: Rebuilding Air Cargo Operations Through AI-Native Logistics

Sungrow and Sunotec commission Enery’s 150 MW / 600 MWh Battery Storage Project in Bulgaria

Tag: CLF UWS USA NAM CHN ASA

Pearl Studio and CMC Pictures Set Global Summer Release for Animated Comedy Feature All Wishes Come True!

World’s First CLDN18.2 ADC for Regulatory Review: Innovent Biologics Announces IBI343 (arcotatug tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory...

Viewing China from Afar: Ganbei in Napa

Elegoo Launches Nexprint Million-Dollar Creator Fund to Reward Original Content

Nature Medicine Published Phase 1 Results of Innovent Biologics’ Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Synopsys Issues Statement in Connection to the Lifting of Recent U.S. Export Restrictions Related to China

Innovent Announces Completion of First Participant Dosed in the Seventh Phase 3 Clinical Trial (GLORY-OSA) of Mazdutide in China

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us